Pabau Engage inbox

Pabau Engage is here: every patient conversation in one inbox.

Learn more
Book a demo Book a demo
☰
CCSD Code

CCSD code C2220 – Eyelid lesion biopsy


Code Definition

C2220 is the CCSD code for biopsy of lesion of eyelid, in Chapter 4 under Eyebrow and lid. It covers taking a tissue sample from an upper or lower lid lesion so histopathology can confirm the diagnosis.

The clinical intent decides the code. If the surgeon removes the whole lesion to treat it, the procedure bills as C1210, and curettage or cryotherapy bills as C1230. The laboratory bills its analysis separately, and UK private medical insurers expect pre-authorization.

Group
4 Eye and orbital contents
Category
Eyebrow And Lid
Subcategory
C2220 Biopsy of lesion of eyelid
Code also known as
eyelid biopsy, periorbital lesion biopsy, eyelid skin biopsy, oculoplastic biopsy, eyelid tissue sampling
Save time. Improve accuracy. Get paid faster.
Automate coding with Pabau

Let Pabau's smart automation suggest the right codes, reduce claim denials, and keep your practice compliant—effortlessly.

  • AI-powered code suggestions
  • Real-time compliance checks
  • Faster claims, fewer denials
Why practices choose Pabau
Save hours every week

Automate repetitive tasks and focus on what matters most—your patients.

Improve accuracy

Reduce coding errors and ensure compliance with the latest regulations.

Get paid faster

Clean claims, fewer denials, and faster reimbursements.

Grow with confidence

Powerful insights and reporting to help your practice thrive.

HIPAA compliant SOC 2 certified GDPR-compliant Trusted by 4,000+ clinics worldwide

Key takeaways

Key takeaways

CCSD code C2220 covers a biopsy of an eyelid lesion in UK private practice and is not part of NHS OPCS-4 coding.

The code pays for the surgeon’s operative work only, so the laboratory bills histopathology of the specimen as a separate charge.

Clinical intent decides the code: a diagnostic sample is C2220, a full excision is C1210, and curettage or cryotherapy is C1230.

A missing pre-authorization reference is the most avoidable denial, because most UK private insurers will not authorize the procedure after the event.

Pabau, the practice management platform we build, flags a missing authorization on the patient’s case and sends UK claims through Healthcode and BUPA.

CCSD Code C2220: Official descriptor and clinical scope

CCSD Code C2220 is the Committee of Coding and Schedule Descriptors procedure code for the biopsy of a lesion of the eyelid. The official descriptor is “Biopsy of lesion of eyelid.” The CCSD, whose members represent Bupa, AXA Health, Aviva and Vitality, publishes the UK private healthcare coding schedule.

The code applies only to procedures billed through private medical insurance or self-pay in the United Kingdom.

The code captures the full surgical episode of taking a tissue sample from an eyelid lesion for diagnostic purposes.

It covers patient preparation, local anesthetic and the biopsy itself, whether incisional, excisional or punch. Wound closure and specimen handling are included up to the point the sample leaves the operating field. It does not extend to laboratory analysis of the specimen.

C2220 sits in Chapter 4 of the schedule, Eye and orbital contents, under Eyebrow and lid. The same chapter covers the orbit behind the lid, where removal of a foreign body is billed as C0640. Consultant ophthalmologists and oculoplastic surgeons use it most. Dermatologists in private secondary care may also use it when an eyelid biopsy forms part of a consultant-led episode.

Its neighbors in that chapter cover excision, curettage and grafting of the same lid, and they share the same documentation pattern. For codes in other chapters, see our full list of CCSD procedure codes. Circumcision, for example, sits in chapter 12 under code N3030.

The procedure: What happens during a biopsy of an eyelid lesion

An eyelid lesion biopsy is a minor surgical procedure performed under local anesthesia in an outpatient setting. General anesthesia is reserved for exceptional cases, such as a pediatric patient or a lesion in a location where local infiltration is contraindicated.

Three biopsy techniques may be used depending on lesion size, location, and clinical suspicion:

  • Incisional biopsy: A representative wedge of tissue is removed from part of the lesion, leaving the remainder in situ. Used when the lesion is large, when complete excision risks eyelid function, or when histological confirmation is needed before planning definitive surgery.
  • Excisional biopsy: The entire lesion is removed with a small margin of normal tissue. The specimen is sent for histopathology. Used for small lesions where complete removal and diagnosis can be achieved in a single procedure. Where treating the lesion was the aim, check the excision code covered below.
  • Punch biopsy: A circular dermal punch (typically 2-4 mm) samples the lesion. Less commonly used on the eyelid margin but appropriate for flat, dermal lesions on the lid skin away from the margin.

Whatever the technique, the operative note must record five details:

  • The specific biopsy method
  • The site on the eyelid: upper lid, lower lid, medial canthus or lateral canthus
  • The approximate dimensions of the sample
  • The type of closure: suture, tissue glue or healing by secondary intention
  • Confirmation that the specimen was labeled and dispatched to histopathology

The documentation section below lists what the wider record needs.

Clinical indications: When is C2220 appropriate?

CCSD Code C2220 is appropriate whenever a formal tissue biopsy of an eyelid lesion is performed to establish or confirm a histological diagnosis. Both benign and malignant lesions may justify the code, provided the clinical decision to biopsy rather than observe or excise has been documented.

Common lesion types that appropriately trigger a C2220 billing event include:

  • Basal cell carcinoma (BCC): The most common malignant eyelid tumor, accounting for approximately 90% of eyelid malignancies. Biopsy before definitive excision or Mohs surgery is standard practice.
  • Squamous cell carcinoma (SCC): Less common than BCC but more aggressive; biopsy is essential before surgical planning.
  • Sebaceous gland carcinoma: A rare but clinically significant malignancy that can mimic a chalazion; biopsy is the definitive diagnostic step.
  • Xanthelasma: Benign lipid deposits on the lid skin; biopsy is performed when the diagnosis is uncertain or the presentation is atypical.
  • Pigmented lesions: Any pigmented or atypical nevus of the eyelid where melanoma cannot be excluded clinically.
  • Inflammatory or granulomatous lesions: Persistent granulomas unresponsive to treatment, where sarcoidosis or other systemic pathology needs to be ruled out.

A chalazion (meibomian gland cyst) is not coded as C2220 when no formal biopsy goes to histopathology. A chalazion treated by curettage bills as C1230, and one excised in full bills as C1210. If the clinician also samples tissue because of atypical features, C2220 covers the biopsy component.

What CCSD Code C2220 billing includes, and what it excludes

Understanding bundling rules prevents over-billing, under-billing, and claim rejection. The table below summarizes what is in-scope for C2220 and what must be coded or billed separately.

ItemIncluded in C2220?Notes
Surgeon’s operative workYesFrom local anesthetic administration to wound closure and specimen dispatch
Local anesthetic drug costYes (typically)Minor consumables are generally bundled; confirm with individual insurer schedules
Histopathology / laboratory analysisNoBilled separately by the pathologist or laboratory under the relevant pathology code
Anesthetist fee (if GA used)NoAnesthetist bills independently; general anesthesia is rare for this procedure
Pre-operative outpatient consultationNoBilled as a separate new or follow-up outpatient attendance code
Post-operative review appointmentsNoCoded as follow-up outpatient attendances; some insurers include one follow-up in the surgical package
Definitive excision performed at same sittingNoIf the whole lesion is excised to treat it, C1210 (excision of lesion of eyelid) applies instead

Pro Tip

Always check the individual insurer’s current fee schedule before submitting. Bundling conventions vary between Bupa, AXA Health, Aviva, and Vitality, and what one insurer bundles another may allow as a separate charge. Never rely on a single payer’s rules as a universal standard.

Adjacent CCSD codes: How C2220 differs from C1210 and C1230

Selecting the wrong adjacent code is one of the most common coding errors in oculoplastic billing. The table below shows the codes most frequently confused with C2220 and the key differentiator for each.

CodeDescriptorKey differentiator from C2220Use instead when…
C2220Biopsy of lesion of eyelidTissue sampling only; diagnosis is the primary goalPartial tissue sample taken for histopathology; lesion remains partially or fully in situ
C1210Excision of lesion of eyelidComplete removal is the primary intent; histopathology is a secondary resultEntire lesion is excised with clear margins; specimen sent for confirmatory histology
C1230Curettage/cryotherapy of lesion of eyelidThe lesion is treated by scraping or freezing, not sampledThe lesion is curetted or destroyed by cryotherapy
C1230 or C1210 (chalazion)Chalazion treated by curettage (C1230) or excised in full (C1210)Treatment of the cyst; no formal biopsy sent for histopathologyUse C1230 for curettage and C1210 for full excision

Critical distinction: Clinical intent separates C2220 from C1210, whatever the size of the tissue removed. If the surgeon set out to remove the lesion and histopathology only confirms it, C1210 is correct. If the goal was diagnosis and the lesion was not fully cleared, C2220 applies.

Curettage or cryotherapy of the lesion is C1230. Insurers check the operative note against the code, so a mismatch is a frequent denial trigger. The diagram below maps each intent to its code.

Decision diagram for CCSD eyelid lesion codes: a biopsy that samples the lesion for diagnosis is C2220, full excision including a chalazion removed in full is C1210, and curettage or cryotherapy including chalazion curettage is C1230; histopathology is billed separately in every case
The same lid lesion can carry three different codes, depending on what the operative note says the procedure set out to do. Descriptors follow the CCSD schedule, Chapter 4.

Check adjacent code numbers against the current CCSD schedule before submitting, because the schedule is updated periodically. Our Bupa CCSD code guide shows how these codes map to an insurer fee schedule.

Documentation requirements for a valid CCSD Code C2220 claim

A clean C2220 claim depends on a complete operative note and a well-structured patient record. Insurers increasingly audit surgical claims against submitted documentation, and vague or incomplete notes are a primary rejection trigger.

The operative note for a C2220 procedure must include all of the following:

  • Patient identifier and date of procedure
  • Diagnosis or clinical suspicion justifying the biopsy (e.g. “suspected BCC lower lid,” “atypical pigmented lesion medial canthus”)
  • Specific anatomical location on the eyelid: Upper lid, lower lid, medial or lateral canthus, lid margin
  • Biopsy technique used: Incisional, excisional, or punch – with dimensions of the sample where relevant
  • Anesthetic modality: Local infiltration (agent and volume), or general anesthesia with anesthetist details
  • Wound closure method: Suture type and size, tissue glue, or healing by secondary intention
  • Specimen handling: Confirmation that the specimen was labeled, placed in fixative, and dispatched to a named laboratory
  • Surgeon’s name and GMC number

Beyond the operative note, the patient record should hold the outpatient letter that documents the decision to biopsy rather than excise. It also needs the insurer’s pre-authorization reference and, where applicable, the referring GP or specialist letter.

Digital clinical forms keep these records structured, timestamped and retrievable during an audit. GMC and ICO guidance governs how long surgical notes are kept. Practices should keep operative notes for at least eight years for adult patients.

Digital forms
Pabau’s digital forms prompt for the biopsy method, lid site and specimen dispatch, so the operative note behind a C2220 claim is complete.

Pre-authorization: What UK private insurers require before approving C2220

All major UK private medical insurers require pre-authorization for surgical procedures, including CCSD Code C2220. Submitting a claim without an authorization reference number is the single most avoidable reason for denial. Pre-authorization must be obtained before the procedure takes place; retrospective authorization requests are routinely refused or result in reduced settlement.

The table below summarizes the pre-authorization approach for the principal UK private insurers. Because insurer policies change, always verify requirements directly with each insurer’s provider portal before the procedure.

InsurerPre-auth required?Referral routeKey notes
BupaYesGP or consultant referral; Bupa GP referral required in most plansUse the Bupa code search portal to verify C2220 coverage and applicable fee level before submitting
AXA HealthYesGP referral required for most policies; some open-referral plans existProcedure codes and fee chapters on AXA Health’s specialist forms portal
AvivaYesGP referral via MyAviva app or provider phone lineFee schedule published on Aviva’s provider fee schedule; verify CCSD chapter before quoting a fee
Vitality HealthYesGP referral; member can self-refer to named specialists on some plansConfirm C2220 reimbursement rates with Vitality before the procedure
HealixYesCorporate scheme referral; employer sponsor often involvedFees and unbundling rules on the Healix fee schedule

Billing histopathology alongside C2220

Histopathology of the biopsy specimen is not bundled within CCSD Code C2220. The surgical code covers only the work of the operating consultant, up to and including dispatch of the labeled specimen. Laboratory work is a separate charge, whether standard histology, immunohistochemistry or frozen-section analysis. The pathologist or laboratory bills it under the applicable pathology CCSD code.

Three common billing configurations arise in practice:

  • Surgeon bills C2220; hospital laboratory bills histopathology separately. This is the standard configuration when the procedure is performed in a private hospital with an in-house laboratory. The lab raises its own invoice directly to the insurer.
  • Surgeon bills C2220; external laboratory bills histopathology directly. When the specimen is sent to an external laboratory, that laboratory invoices the insurer independently. The surgeon’s invoice and the laboratory invoice should not duplicate any item.
  • Surgeon bills both C2220 and a separate pathology code. Some consultants in solo or small-group practice provide the histopathology report through their own practice. They bill the pathology component under the relevant CCSD pathology code. This is permissible but requires clear documentation of the arrangement and must not result in double-billing.

Confirm the insurer’s position on histopathology billing in advance. Some plans require the laboratory to bill directly; others allow the consultant to consolidate charges. Submitting a histopathology charge within the C2220 invoice when the insurer expects separate billing is a denial trigger.

Common claim denial reasons for C2220 and how to avoid them

Knowing the most frequent denial reasons for CCSD Code C2220 makes it possible to prevent most of them before submission. The list below draws on standard UK private practice billing experience; individual insurer denial patterns may vary.

  • No pre-authorization reference: The claim is submitted without a valid authorization number. Prevention: Obtain pre-auth before every procedure, record the reference number in the patient record, and include it on every invoice.
  • Wrong code selected (C2220 vs C1210): The operative note describes complete excision but C2220 (biopsy) was submitted. Prevention: Match the code to the clinical intent documented in the note, not to the size of the tissue removed.
  • Insufficient operative note: The note lacks the anatomical site, biopsy technique, or specimen handling details the insurer requires to validate the procedure. Prevention: Use a structured operative note template that covers all mandatory elements before dispatch.
  • Histopathology bundled incorrectly: The lab fee is included in the C2220 invoice when the insurer expects a separate submission. Prevention: Establish the insurer’s preferred billing route for each plan type.
  • No GP referral on file: The insurer’s policy requires a GP referral letter but none was obtained. Prevention: Confirm referral requirements at the point of booking and retain a copy in the patient record.
  • Policy exclusion for cosmetic or elective procedures: The insurer classes the lesion as cosmetic because the clinical reason for the biopsy was not documented. Prevention: Include explicit clinical reasoning in the correspondence – “biopsy to exclude malignancy” carries more weight than a bare code submission.

A pre-submission check for the authorization reference and a complete operative note, run before the invoice leaves the practice, prevents most first-contact denials.

HIPAA compliance toggle
Pabau’s compliance settings keep patient records protected, so the operative notes behind a C2220 claim are ready when an insurer audits them.

How Pabau supports C2220 claims and pre-authorization

A C2220 claim fails at three points: the code chosen against the operative note, the pre-authorization reference, and the submission itself. In a practice that bills from spreadsheets and insurer portals, each one is a manual check.

Pabau records the authorization code, dates and sessions on the patient’s case and warns the team when an authorization is missing. Claims then go to UK insurers electronically through Healthcode and BUPA, using Pabau’s claims management software.

Automate claims through Healthcode
Pabau submits C2220 claims through Healthcode, so the claim reaches the insurer electronically instead of on a paper form.

For a practice with several consultants, the operative note, the authorization and the claim sit on one patient record. Billing staff can see whether a C2220 claim is ready without checking each insurer’s portal by hand.

Get C2220 claims paid the first time

Pabau tracks pre-authorization codes on the patient’s case and warns you when one is missing. UK claims then go to insurers through Healthcode and BUPA.

Pabau practice management dashboard for private practice billing

Conclusion

Code C2220 only when the operative note shows a diagnostic sample. When the procedure set out to treat the lesion, use C1210 or C1230 instead. That one decision, written down before the claim goes out, removes the most common reason insurers query an eyelid biopsy.

The rest is routine: secure the authorization first and let the laboratory bill histology on its own invoice. Practices that build these checks into booking spend less time on resubmissions. Book a demo to see how Pabau keeps authorizations and C2220 claims in one place.

Continue your research

Continue your research

Need a full Bupa billing reference? Bupa CCSD procedure code guide covers Bupa’s fee structure, code submission rules, and pre-authorization conventions across the full CCSD schedule.

Was the whole lesion removed? CCSD code C1210 covers excision of a lesion of the eyelid, including a chalazion excised in full.

Treated by curettage or freezing? CCSD code C1230 covers curettage or cryotherapy of an eyelid lesion.

Closing the defect with a graft? CCSD code C1420 explains how an eyelid skin graft is coded and billed.

Frequently asked questions

What does CCSD Code C2220 cover?

CCSD Code C2220 covers the biopsy of a lesion of the eyelid in UK private healthcare. It pays for the surgeon’s work from local anesthetic through sampling and wound closure to specimen dispatch. It does not include histopathology fees, anesthetist charges, or separate consultation attendances.

What is the difference between C2220 biopsy and eyelid lesion excision in CCSD coding?

C2220 is used when the primary clinical intent is diagnosis through tissue sampling, with the lesion remaining partially or fully in situ. C1210 (excision of lesion of eyelid) applies when the primary intent is complete removal of the lesion, with histopathology as a confirmatory step. The operative note must clearly reflect which intent drove the clinical decision.

Does C2220 include histopathology of the biopsy specimen?

No. Histopathology is not bundled within C2220 and must be billed separately by the pathologist or laboratory under the applicable pathology code. Some insurers require the laboratory to submit its own invoice; others allow the consultant to consolidate charges. Confirm the insurer’s preferred arrangement before submitting.

Do UK private insurers require pre-authorization for CCSD C2220?

Yes. All major UK private medical insurers, including Bupa, AXA Health, Aviva, and Vitality Health, require pre-authorization for surgical procedures including C2220. Authorization must be obtained before the procedure takes place; retrospective requests are routinely refused. Always record the authorization reference number in the patient record and include it on the invoice.

How should a chalazion be coded rather than as C2220?

A chalazion treated by curettage, with no formal biopsy sent for histopathology, is coded C1230. One excised in full is coded C1210. C2220 applies only when the clinician also takes a tissue sample because atypical features could indicate malignancy.

Why would a C2220 claim be denied by Bupa or AXA Health?

The most common reason is a missing pre-authorization reference on the invoice. Others include an operative note that describes excision under a biopsy code, or one missing the lid site. Histopathology bundled into the C2220 invoice is another. Each of these is preventable through structured pre-submission checking.

Tanja Lepcheska
Content Writer

Tanja is a Senior Content Writer who has a skill to turn complex med spa topics into easy, engaging reads that actually make sense. She loves helping clinic owners feel confident about growing their business. When she’s not writing, you’ll probably find her rewatching her favorite romantic movies, working on a new crochet project, or rearranging her home decor “just one more time.”
×